Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta‐analysis
Open Access
- 7 February 2020
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 43 (5), 450-458
- https://doi.org/10.1002/clc.23341
Abstract
Background Although radiofrequency ablation is widely used in the treatment of arrhythmias, its role in septal reduction therapy of hypertrophic obstructive cardiomyopathy (HOCM) is unclear. This meta‐analysis aimed to assess the efficacy and safety of radiofrequency septal ablation for HOCM. Hypothesis Radiofrequency septal ablation is effective and safe for relieving obstruction and improving exercise capacity in patients with HOCM. Methods A systematic review of eligible studies that reported outcomes of patients with HOCM who underwent radiofrequency septal ablation was performed using PubMed, Embase, Cochrane, ProQuest, Scopus, ScienceDirect, and Web of Science database. Pooled estimates were calculated using random‐effects meta‐analysis. Methodological quality was assessed using the Newcastle‐Ottawa scale. Publication bias and sensitivity analyses were also performed. Results Eight studies with 91 patients (mean follow‐up 11.6 months) were included. The left ventricular outflow tract (LVOT) gradient at rest decreased significantly after radiofrequency septal ablation (pooled reduction: −58.8 mmHg; 95% confidence interval [CI] −64.3 to −53.5). A reduction was also found in the provoked LVOT gradient with a pooled reduction of −97.6 mmHg (95% CI: −124.4 to −87.1). An improvement of the New York Heart Association classification (mean: −1.4; 95% CI: −1.6 to −1.2) was found during follow‐up. The change in septal thickness was minimal and not statistically significant. Two procedure‐related deaths were documented, and complete heart block occurred in eight patients. Conclusions Radiofrequency septal ablation is effective and safe for relieving LVOT obstruction and improving exercise capacity in patients with HOCM.Keywords
This publication has 27 references indexed in Scilit:
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Angiographic and Echocardiographic Correlates of Suitable Septal Perforators for Alcohol Septal Ablation in Hypertrophic Obstructive CardiomyopathyCanadian Journal of Cardiology, 2014
- Percutaneous Radiofrequency Septal Reduction for Hypertrophic Obstructive Cardiomyopathy in ChildrenJournal of the American College of Cardiology, 2011
- Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Multicenter North American RegistryJournal of the American College of Cardiology, 2011
- Endocardial Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy: Acute Results and 6 Months’ Follow-Up in 19 PatientsJournal of the American College of Cardiology, 2011
- Quality Control in Systematic Reviews and Meta-analysesEuropean Journal of Vascular and Endovascular Surgery, 2010
- The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: From Idiopathic Hypertrophic Subaortic Stenosis to Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2009
- Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhoodClinical Research in Cardiology, 2005
- Endocardial radiofrequency ablation of septal hypertrophyClinical Research in Cardiology, 2004
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000